Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SZSE:002864's Days Payable is ranked better than 59.81% of 928
companies
in the Drug Manufacturers industry
Industry Median: 88.385
vs SZSE:002864: 106.35
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shaanxi Panlong Pharmaceutical Group Co Days Payable Chart
Shaanxi Panlong Pharmaceutical Group Co Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Shaanxi Panlong Pharmaceutical Group Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shaanxi Panlong Pharmaceutical Group Co Days Payable vs Drug Manufacturers Industry
Shaanxi Panlong Pharmaceutical Group Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shaanxi Panlong Pharmaceutical Group Co (SZSE:002864) has a Days Payable of 132.43 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shaanxi Panlong Pharmaceutical Group Co and its competitors. This is 49% above median its historical median of 89.09. Over the past decade, Shaanxi Panlong Pharmaceutical Group Co's Days Payable has ranged from 61.52 to 158.65. According to the industry distribution chart, Shaanxi Panlong Pharmaceutical Group Co ranks #373 out of 928 companies in the Drug Manufacturers industry, placing it in the top 40.2%.
Is Shaanxi Panlong Pharmaceutical Group Co's Days Payable too high?
Shaanxi Panlong Pharmaceutical Group Co's current Days Payable of 132.43 is 49% above median its 10-year median of 89.09. Over the past 10 years, this metric has ranged from a low of 61.52 to a high of 158.65. The Drug Manufacturers industry median Days Payable is 88.39. Shaanxi Panlong Pharmaceutical Group Co's value of 132.43 is 49.8% above this industry median. Based on the distribution chart, Shaanxi Panlong Pharmaceutical Group Co ranks #373 out of 928 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Shaanxi Panlong Pharmaceutical Group Co has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shaanxi Panlong Pharmaceutical Group Co's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Shaanxi Panlong Pharmaceutical Group Co ranks #373 out of 928 companies for Days Payable. This puts Shaanxi Panlong Pharmaceutical Group Co in the upper half of its industry. The industry median Days Payable is 88.39. Shaanxi Panlong Pharmaceutical Group Co's value of 132.43 is 49.8% above this benchmark. Historically, Shaanxi Panlong Pharmaceutical Group Co's own Days Payable has ranged from 61.52 to 158.65 over the past decade. While the company's 10-year median is 89.09 vs. the industry median of 88.39, Shaanxi Panlong Pharmaceutical Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 88.39, based on 928 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shaanxi Panlong Pharmaceutical Group Co's current Days Payable of 132.43 is 49.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shaanxi Panlong Pharmaceutical Group Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 88.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shaanxi Panlong Pharmaceutical Group Co's current Days Payable is 132.43, which is 49% above median its own 10-year median of 89.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shaanxi Panlong Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Shaanxi Panlong Pharmaceutical Group Co (SZSE:002864) is currently considered Fairly Valued. The stock's GF Value™ is ¥21.61, compared to a current price of ¥20.36 — trading 5.8% below its estimated fair value. The current Days Payable is 132.43, which is 49% above median its 10-year median of 89.09 and 49.8% above the Drug Manufacturers industry median of 88.39. Shaanxi Panlong Pharmaceutical Group Co's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Shaanxi Panlong Pharmaceutical Group Co (SZSE:002864), the current Days Payable is 132.43 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shaanxi Panlong Pharmaceutical Group Co (SZSE:002864) Overvalued in 2026?
Based on GuruFocus' analysis, Shaanxi Panlong Pharmaceutical Group Co stock appears to be undervalued.
The current stock price of ¥20.36 is trading 5.8% below its estimated GF Value™ of ¥21.61.
GuruFocus considers Shaanxi Panlong Pharmaceutical Group Co to be Fairly Valued.
Key valuation signals for SZSE:002864:
Days Payable: 132.43 (49% above median its 10-year median of 89.09)
GF Value™: ¥21.61 vs. price of ¥20.36 (5.8% below fair value)
Industry Position: 49.8% above the Drug Manufacturers median (#373 of 928)
No single metric tells the full story. See the SZSE:002864 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shaanxi Panlong Pharmaceutical Group Co Ltd is engaged in the cultivation of medicinal herbs under Good Agricultural Practices (GAP), pharmaceutical production, research and development, sales, and logistics activities. Its business scope also includes technology and goods import and export, import and export agency services, medical research and experimental development, and the sale of hygiene products, disposable medical supplies, and disinfectants.
85GF Score
Get the complete analysis for SZSE:002864
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:002864 has been successfully added to your 
